Publications by authors named "C B Demirel"
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) requires advanced techniques and prolonged procedural efforts, often necessitating high contrast volumes, which may increase the risk of contrast-associated acute kidney injury (CA-AKI). However, evidence suggests that factors beyond contrast exposure contribute to CA-AKI, though data specific to CTO PCI remain limited. Patients undergoing contemporary CTO PCI at our university-affiliated tertiary care center were enrolled.
View Article and Find Full Text PDFArticle Synopsis
- This study explores the link between ABO blood groups and the risk of early stent thrombosis in patients who underwent coronary interventions, focusing particularly on non-O blood groups and their association with cardiovascular issues.
- Among 10,714 patients, only 0.73% experienced early stent thrombosis, and while non-O blood groups weren't significantly linked, those with B-antigens (B and AB blood types) showed a higher risk for early thrombosis compared to O type.
- The findings suggest that B-antigen presence is a notable factor in early stent thrombosis risk, indicating a need for more research to understand the biological mechanisms behind this relationship.
We aimed to investigate whether pulsed magnetic fields (PMFs) (1 mT) may have preventive effects on myocardial damage and apoptosis in rats with sepsis. Twenty-eight adult Wistar albino rats were evenly distributed among four experimental groups, each consisting of seven rats: SH, LF-PMF, HF-PMF, and CLP. Sepsis induction was carried out via the cecal ligation and puncture (CLP) method, while rats in the LF-PMF and HF-PMF groups were exposed to 7.
View Article and Find Full Text PDFBackground: Preprocedural evaluation, including frailty estimation, is crucial in managing patients undergoing Transcatheter Aortic Valve Replacement (TAVR). This involves mandatory computed tomography (CT) scans for assessing body composition parameters. The impact of low bone mineral density (BMD) on TAVR outcomes remains unclear, especially when measured using both non-enhanced and contrast-enhanced CT scans.
View Article and Find Full Text PDFAdjuvant letrozole administration in gonadotropin releasing hormone antagonist cycles do not affect ploidy status of embryos.
J Gynecol Obstet Hum Reprod
October 2023
Article Synopsis
- The study aimed to assess how adjuvant letrozole affects the rate of euploid embryos in patients undergoing GnRH antagonist cycles for fertility treatments.
- It analyzed data from 713 patients, comparing 84 who received letrozole with 629 who did not, noting that those on letrozole used fewer gonadotropins but had a slightly longer stimulation time.
- The results showed no significant difference in euploidy rates or live birth rates between the letrozole and control groups, concluding that letrozole does not impact embryo quality in this context.